Extending Mesothelioma Survival with Chemotherapy

In the continued quest to improve the effectiveness of chemotherapy treatment for malignant pleural mesothelioma, two new studies have been published this week on the effectiveness of adding additional drugs to the standard combination. The majority of patients who receive a mesothelioma diagnosis will have treatment that includes chemotherapy. According to data from the National Cancer Institute’s SEER database, the chemotherapy regimen prescribed most often … Continue reading Extending Mesothelioma Survival with Chemotherapy »

New Immunotherapy Drug Stops Mesothelioma in Half of Patients Tested

The results are in on the Phase I/II trial of the mesothelioma drug ONCOS-102 and researchers say there is reason to be excited. As Surviving Mesothelioma first reported in the fall of 2016, ONCOS-102 and standard chemotherapy significantly slowed the growth of malignant mesothelioma tumors in preclinical studies of infected mice. Now, the first human trial suggests that it can do the same thing in … Continue reading New Immunotherapy Drug Stops Mesothelioma in Half of Patients Tested »

“Spray On” Drugs May Be New Option for Peritoneal Mesothelioma Patients

Surgery for Peritoneal Mesothelioma

A new, minimally-invasive way of delivering drugs right to the site of a tumor is being called “safe and feasible” for people with recurrent malignant mesothelioma. Right now, mesothelioma patients whose cancer comes back after surgery and systemic chemotherapy have few viable treatment options. The new procedure, called Pressurized Inraperitoneal Aerosol Chemotherapy (PIPAC), may change that. During PIPAC, chemotherapy drugs are essentially “sprayed” as gas … Continue reading “Spray On” Drugs May Be New Option for Peritoneal Mesothelioma Patients »

Study Finds Chemotherapy Unlikely to Improve Peritoneal Mesothelioma Survival

A new study from the University of Illinois suggests that patients with peritoneal mesothelioma who undergo  surgery may not get any benefit from having chemotherapy, too. Mesothelioma patients who have cytoreductive surgery, which is also called debulking surgery, tend to live more than four times as long as those who do not have the surgery. Rinsing the abdominal cavity with a heated solution of cancer-killing … Continue reading Study Finds Chemotherapy Unlikely to Improve Peritoneal Mesothelioma Survival »

Home-Based Rehab Helps Mesothelioma Patients Bounce Back After Chemotherapy

New evidence suggests that a pulmonary rehabilitation program that comes to them might help patients recover after pleural mesothelioma treatment. Experts in pulmonary cancers at several French institutions recently published what they called a “real-life feasibility study” of home-based rehab in patients who had received chemotherapy for either lung cancer or malignant pleural mesothelioma. Previous research has shown that these patients are typically less physically … Continue reading Home-Based Rehab Helps Mesothelioma Patients Bounce Back After Chemotherapy »

Simple Blood Test Detects Mesothelioma Progression

Malignant mesothelioma patients may not need multiple CT scans to tell whether their cancer has progressed in the months after  chemotherapy treatment. UK researchers say a simple blood test to check their levels of the protein mesothelin costs less, requires fewer hospital visits, and is 96 percent accurate in most mesothelioma patients.   Measuring Mesothelioma Progression The study was conducted by scientists at the University … Continue reading Simple Blood Test Detects Mesothelioma Progression »

Mini-Tumors May Help Doctors Develop Personalized Mesothelioma Treatments

Doctors at Wake Forest University are using miniature lab-grown three dimensional tumors to test personalized mesothelioma treatments. The mini-tumors are known as organoids and are grown from biopsy tissue taken from patients diagnosed with mesothelioma. Researchers say they can serve as models to try out new mesothelioma therapies before using them on patients. “There is a need for model systems to help predict personalized responses … Continue reading Mini-Tumors May Help Doctors Develop Personalized Mesothelioma Treatments »

Clinical Trials Often the Best Option for Malignant Mesothelioma

Newly-diagnosed patients with malignant mesothelioma are forced to face a harsh reality early on in their cancer journey – there is no universally effective treatment for this aggressive cancer. In fact, as a highly resistant malignancy, mesothelioma is often unresponsive to even the “gold standard” treatment combination of pemetrexed (Alimta) and cisplatin. But that does not mean that mesothelioma patients do not have options. Clinical … Continue reading Clinical Trials Often the Best Option for Malignant Mesothelioma »

Mesothelioma Treatment May Be More Effective Without This Enzyme

An international team of researchers has published data they believe could dramatically boost the effectiveness of chemotherapy for malignant mesothelioma. Malignant mesothelioma is a highly lethal, asbestos-linked cancer. One of the reasons it is so difficult to cure is that it is resistant to all of the standard cancer drugs. Now, scientists with the University of New Mexico, the University of Kansas, and Semmelweis University … Continue reading Mesothelioma Treatment May Be More Effective Without This Enzyme »

Managing Taste and Smell Changes During Mesothelioma Treatment

If you are a mesothelioma patient dealing with changes in how you taste or smell your food, you are not alone. A new study of lung cancer patients in the same situation suggests that healthcare professionals could be doing more to help. Treatment-related changes in taste and smell are common among people with malignant mesothelioma and other types of cancer. Chemotherapy can change a person’s … Continue reading Managing Taste and Smell Changes During Mesothelioma Treatment »

Get your free copy of
“Surviving Mesothelioma” Today!